Of note, although the data on hepatic chemerin mRNA expression in NASH patients were inconsistent, most studies indicated that hepatic chemerin mRNA expression was closely correlated with inflammation and hepatic fibrosis (54). The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatohepatitis.